Canadian Cancer Society funds lung cancer research projects
Seven new grants were awarded to researchers at the British Columbia (B.C.) Cancer Agency, University of British Columbia and the University of Victoria for undertaking studies in a variety of cancer research projects. The combined total investment from the Canadian Cancer Society in seven new and twenty-three continuing grants is approximately $23 million.

The new projects focus on better methods to improve the detection of cancers earlier and to find more effective, less harmful treatments.

The new grant recipients include:
  • Wan Lam, PhD, BC Cancer Agency in Vancouver, who will use a new type of computer software to compare the genetic profile of tumors in smokers and non-smokers to identify if there are different genes mutated in non-smoker lung cancers.
  • David Perrin, PhD, University of British Columbia, who is working to create better PET scan images through development of a new radioactive drug that is easier to produce and is detected by the scan after being injected into the patient and travelling to cancer sites.
  • Catherine Poh, DDS, PhD, University of British Columbia, who is investigating the use of a new hand-held optical tool in the identification of high-risk, pre-cancerous lesions in the mouth during exploratory surgery.
  • Jeremy Wulff, PhD, University of Victoria, who is developing new molecules that interfere with two proteins known to contribute to pancreatic cancer.
  • Haishan Zeng, BC Cancer Agency, will conduct a clinical study of accuracy and usefulness of laser technology to detect early signs of lung cancer.